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Abstract

Background and Purpose
The heteromeric α4β2 nicotinic acetylcholine receptor (nAChR) is abundant in the human brain and is
associated with a range of CNS disorders. This nAChR subtype has been recently crystallised in a
conformation that was proposed to represent a desensitised state. Here, we investigated the
conformational transition mechanism of this nAChR from a desensitised to a closed/resting state.

Experimental Approach
The competitive antagonist dihydro‐β‐erythroidine (DHβE) was modelled by replacement of the agonist
nicotine in the α4β2 nAChR experimental structure. DHβE is used both in vitro and in vivo for its ability to
block α4β2 nAChRs. This system was studied by three molecular dynamics simulations with a combined
simulation time of 2.6 μs. Electrophysiological studies of mutated receptors were performed to validate
the simulation results.

Key Results
The relative positions of the extracellular and transmembrane domains in the models are distinct from
those of the desensitised state structure and are compatible with experimental structures of Cys‐loop
receptors captured in a closed/resting state.

Conclusions and Implications
Our model suggests that the side chains of α4 L257 (9′) and α4 L264 (16′) are the main constrictions in
the transmembrane pore. The involvement of position 9′ in channel gating is well established, but position
16′ was only previously identified as a gate for the bacterial channels, ELIC and GLIC. L257 but not L264
was found to influence the slow component of desensitisation. The structure of the antagonist‐bound
state proposed here should be valuable for the development of therapeutic or insecticide compounds.
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BACKGROUND AND PURPOSE
The heteromeric α4β2 nicotinic acetylcholine receptor (nAChR) is abundant in the human brain
and is associated with a range of central nervous system disorders. This nAChR subtype has
been recently crystallised in a conformation that was proposed to represent a desensitised state.
Here, we investigated the conformational transition mechanism of the nAChR from a
desensitised to a closed/resting state.
EXPERIMENTAL APPROACH
The competitive antagonist dihydro-β-erythroidine (DHβE) was modelled by replacement of
the agonist nicotine in the α4β2 nAChR experimental structure. DHβE is used both in vitro and
in vivo for its ability to block α4β2 nAChRs. This system was studied by three molecular
dynamics simulations with a combined simulation time of 2.6 μs. Electrophysiological studies
of mutated receptors were performed to validate the simulation results.
KEY RESULTS
The relative positions of the extracellular and transmembrane domains in the models are
distinct from those of the desensitised state structure and are compatible with experimental
structures of Cys-loop receptors captured in closed/resting state.
CONCLUSIONS AND IMPLICATIONS
Our model suggests that the side chains of α4 L257 (9’) and α4 L264 (16’) are the main
constrictions in the transmembrane pore. The involvement of Position 9’ in channel gating is
well-established but Position 16’ was only previously identified as a gate for the bacterial
channels, ELIC and GLIC. L257 but not L264 was found to influence the slow component of
desensitisation. The structure of the antagonist-bound state proposed here should be valuable
for the development of therapeutic or insecticide compounds.
Keywords
Ligand-gated ion channel; Cys-loop receptors; activation state; molecular dynamics;
electrophysiology
Abbreviations
nAChR, nicotinic acetylcholine receptor; ACh, acetylcholine; AChBP, acetylcholine binding
protein; DHβE, dihydro-β-erythroidine; MD, molecular dynamics; ECD, extracellular domain;
TMD, transmembrane domain; GlyR, glycine receptor; 5-HT3, serotonin receptor; GABAAR,
γ-aminobutyric acid type A receptor.

Bullet point summary:
What is already known


X-ray and EM structures of the 42 nAChR in a desensitised state.

What this study adds


The 3D structure of the α4β2 nAChR bound to an inhibitor.



Identifications of residues involved in pore gating of nAChRs.

Clinical significance


The structure of nAChRs in a closed state enables the design of nAChR inhibitors.



Specific inhibitors of nAChR subtypes could be used to fight addiction and pain.
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Introduction
The Cys-loop receptors are the most diverse class of ionotropic neurotransmitter-gated ion
channels and are also major contributors to the modulation of neuronal communication
(Cecchini & Changeux, 2015; Nemecz, Prevost, Menny, & Corringer, 2016; Plested, 2016).
Each of these receptors are activated by different neurotransmitters, and the most prevalent
receptors in the brain are the nicotinic acetylcholine (nAChR), glycine (GlyR), serotonin (5HT3) and γ-aminobutyric acid type A (GABAAR) receptors. They have a pseudo-symmetrical
pentameric structure of homologous subunits and display an extracellular domain (ECD), a
transmembrane domain (TMD), and a C-terminal domain. After a period of activation, Cysloop receptors undergo desensitisation, which is an ensemble of non-conducting states
characterised by a high-affinity for agonists (Boyd & Cohen, 1980; daCosta & Baenziger, 2013;
Quick & Lester, 2002). The receptors ultimately recover from desensitisation, adopting an
agonist-sensitive resting state, which can be once again activated.
The nAChR is the prototypical member of the Cys-loop receptors because it was the first to
be identified (Changeux, 2012). The pentameric organisation (Hucho & Changeux, 1973),
agonist binding site location (Oswald & Changeux, 1982), domain organisation and fold
(Unwin, 2005) are shared features of Cys-loop receptors and were all discovered using nAChRs
(Changeux, 2012). Despite the importance of nAChRs in the early characterisation of synaptic
transmission, high-resolution structural biology studies focused on other members of the family
until the recent study of the human α4β2 nAChR subtype in complex with nicotine by EM and
X-ray crystallography (Morales-Perez, Noviello, & Hibbs, 2016; Walsh et al., 2018). As shown
in Figure 1, the α4β2 nAChR ECD is a β-sandwich composed of ten strands, denoted β1 to
β10. The agonist binding sites are located at the interface between two subunits in the ECD
contributed by a β-sheet of the complementary subunit and the A-, B- and C-loops of the
principal subunit. Each subunit contributes to the TMD by four sequential α-helices, M1–M4,
with the M2 helices lining the central channel and interacting with the M1 and M3 helices.
The α4β2 nAChR, which is a pentamer of nAChR α4 subunits and nAChR β2 subunits, was
crystallised in a non-conducting state, with the nicotine bound to the ECD and the TMD
constricted at the intracellular exit (Morales-Perez et al., 2016). This structure was proposed to
represent a desensitised state because of the decreased pore diameter in the intracellular side,
similar to the GABAAR and GlyR structures that were claimed representing desensitised states
(Du, Lü, Wu, Cheng, & Gouaux, 2015; Miller & Aricescu, 2014). It is also known that the α4β2
nAChR desensitises almost completely with steady state application of a high concentration of

nicotine.
Cys-loop desensitised conformations are highly similar to the open state except at the
desensitised gate in the intracellular region of the TMD whereas the resting state is structurally
divergent from other activation states, displaying relative tiltisg and twisting of domains (Du
et al., 2015). Therefore, the resting states of nAChRs are an essential missing element for
describing nAChR activation states. Here we used the crystal structure of the α4β2 nAChR to
build a model of its complex with the competitive antagonist dihydro-β-erythroidine (DHβE),
an Erythrina alkaloid, and investigate the conformational coupling from the ligand binding site
in the ECD to the TMD by performing several molecular dynamics simulations. The resulting
channel conformation displays the common features of Cys-loop receptors in a closed/resting
state.

Methods
Initial model of DHβE binding mode
An initial model displaying an interaction between DHβE and the orthosteric binding site of
α4β2 nAChR was generated using the crystal structures of the complex between AChBP and
DHβE (PDB identifier 4alx; (Shahsavar et al., 2012)) and of human α4β2 nAChR in a
desensitised state and bound by two nicotine molecules (PDB identifier 5kxi; (Morales-Perez
et al., 2016)). Nicotine molecules were replaced by DHβE in the α4β2 nAChR structure by
transferring their coordinates after structural superimposition of AChBP and nAChR ECD.
Limited steric clashes were observed between the C-loops and DHβE molecules, and they were
resolved by minimisation using AMBER 16 (AMBER, RRID:SCR_014230) (Case et al.,
2005).
Molecular Dynamics Simulations
MD simulations of the α4β2 nAChR were performed using AMBER 16 (Case et al., 2005).
The α4β2 nAChR bound with DHβE was inserted in a bilayer containing a 2:2:1 mixture of
POPC

(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine):POPE(1-palmitoyl-2-oleoyl-sn-

glycero-3-phosphoethanolamine):cholesterol, similar to Grossfield et al. (Grossfield, Pitman,
Feller, Soubias, & Gawrisch, 2008), with dimension of 100×101×105 Å and the system
solvated with TIP3P water molecules and Na+ and Cl- ions such that the system was neutral
with an overall concentration of 0.15 M in CHARMM-GUI (http://www.charmm-gui.org) (Lee
et al., 2016). The temperature of the system was gradually increased to 310 K and was
equilibrated for 500 ps in NVT and NPT ensembles, respectively, with the protein and lipids
restrained with 10 kcal/mol/Å2 force. Langevin thermostat was used for the initial heating. For

the second heating phase, an anisotropic Berendsen weak-coupling barostat was used to also
equilibrate the pressure in addition to the use of the Langevin thermostat to equilibrate the
temperature. Then, the position restraints on the membrane were withdrawn and the system
was simulated for 20 ns in NPT. The position restraints on the protein were then gradually
withdrawn in 10 steps of 5 ns MD simulations. Afterwards, unrestrained production run was
performed. In the production run, the temperature was controlled using the Langevin
thermostat while pressure was controlled using the anisotropic Berendsen barostat. Three
production run simulations, referred to here as Simulations 1, 2 and 3, were carried out for 700
ns, 700 ns and 1200 ns, respectively (Table S1). The three simulations were started from
independently equilibrated systems. All simulations were performed using the Lipid14 force
field (Dickson et al., 2014) for the lipids, AMBER14SB force field (Maier et al., 2015) for the
protein, and the GAFF force field (Wang, Wolf, Caldwell, Kollman, & Case, 2004) for DHβE.
The MD simulations used a time step of 2 fs, and all bonds involving hydrogen atoms were
maintained to their standard length using the SHAKE algorithm (Ryckaert, Ciccotti, &
Berendsen, 1977). Particle mesh Ewald (Darden, York, & Pedersen, 1993) was used with a
cutoff of 10 Å for non-bonded atoms interactions and neighbour lists were updated every 10
steps. The Berendsen barostat is not ideal for simulations displaying large volume fluctuations
(Shirts, 2013), however, this barostat was used because it was employed during the
parametrisation of the lipid14 force field (Dickson et al., 2014) and because the volume of the
system was stable during the production run simulations. After 400 ns all three simulations
reached equilibrium according to the backbone root-mean-square deviation from the starting
conformation of the production run (Figure S1). Average values reported in the text were
computed as the average values for the three simulations from 400 ns to the end of each
simulation.
Tilt angle calculations
The tilting angle of each subunit in the ECD was determined by measuring angles between the
individual β-sheet core axes and the axis of the receptor in cylindrical coordinates. The Z-axis
was defined as the channel axis and radial vectors r are perpendicular to the Z-axis. The
principal axis of each subunit in the ECD was obtained by 3D least-square fitting of the
Cartesian coordinates of the Cα atoms. The following definitions of the β-sheet core of each
ECD subunit were used: residues 1–208 in the α4 subunit and residues 1–207 in the β2 subunit.
The ECD radial tilt angle of each subunit in the ECD is the angle between the Z-axis and the
projected principal axis of each subunit in the ECD onto the plane defined by the Z and r, which

points from Z to the centre of the centre of mass (COM) of the subunit in the ECD. The ECD
tangential tilt angle in the ECD is the angle between the Z-axis and the projected principal axis
of each subunit in the ECD onto the plane perpendicular to r. The M2 tilt angles were calculated
using the same method as the ECD radial tilt angle. The M2 helix includes residues 240–262
for the α4 subunit and residues 239–261 for the β2 subunit.
ECD-TMD twist angle calculations
The ECD-TMD twist angle measures the relative displacement of each subunit in the ECD and
in the TMD, corresponding to an angle between two projected vectors in the normal to Z, i.e.
the radial plane. If the projection on the radial plane of the COM of the subunit contribution in
the ECD and in the TMD are along the same radial vector, then the ECD-TMD twist angle of
the subunit is null. In practice, the ECD-TMD twist angle was computed as the angle between
two vectors projected in the radial plane: one vector is defined by the COMs of the entire
receptor and of the subunit in the ECD and the other vector is defined by the COMs of the
entire receptor and the subunit in the TMD.
Radius calculation
The radius of the pore along Z was calculated using the Hole 2.0 program (Smart, Neduvelil,
Wang, Wallace, & Sansom, 1996) after aligning along Z the three-dimensional structures of the
channel. The flow of water passing through the pore was computed using a python script
(Python Programming Language, RRID:SCR_008394) implemented with the MDAnalysis
package (Michaud-Agrawal, Denning, Woolf, & Beckstein, 2011).
Electrophysiology
The [L257A] and [L264A] mutants of α4 subunit were generated using KAPA HiFi HotStart
PCR kit (Roche, Basel, Switzerland) and confirmed by DNA sequencing (Macrogen, Seoul,
South Korea). Plasmid constructs of human (h)α4 and hβ2 nAChR subunits were linearised for
in vitro cRNA transcription using mMessage mMachine transcription kit (AMBION, Foster
City, CA, USA). Stage V-VI oocytes (Dumont’s classification; 1200-1300 μm diameter) were
obtained from Xenopus laevis, defolliculated with 1.5 mg/ml collagenase Type II (Worthington
Biochemical Corp., Lakewood, NJ) at room temperature for 1–2 h in OR-2 solution containing
(in mM) 82.5 NaCl, 2 KCl, 1 MgCl2 and 5 HEPES at pH 7.4. Oocytes were injected with 5 ng
cRNA for human α4β2 (hα4β2) nAChR (concentration confirmed spectrophotometrically and
by gel electrophoresis) using glass pipettes pulled from glass capillaries (3-000-203 GX,
Drummond Scientific Co., Broomall, PA, USA). Oocytes were incubated at 18 ºC in sterile
ND96 solution composed of (in mM) 96 NaCl, 2 KCl, 1 CaCl2, 1 MgCl2 and 5 HEPES at

pH 7.4, supplemented with 5% FBS, 0.1 mg/L gentamicin (GIBCO, Grand Island, NY, USA)
and 100 U/mL penicillin-streptomycin (GIBCO, Grand Island, NY, USA). ND96 solution is
the standard oocyte bathing solution used for electrophysiological recordings. Female X. laevis
were sourced from Nasco (Fort Atkinson, WI, USA) and a maximum of three frogs were kept
in purpose-built 15 l aquarium at 20–26°C with 12 h light/dark cycle within the University of
Sydney Laboratory Animal Services facility. Electrophysiological experiments were performed
using oocytes obtained from three frogs ~five years old. Frogs were anaesthetised with 1.7
mg/ml ethyl 3-aminobenzoate methanesulfonate (pH 7.4 with NaHCO3) and for recovery, postsurgery animals were placed in fresh water at level below the nostrils. Frogs were left to recover
for a minimum of four months between surgeries. Terminal anaesthesia with 5.0 mg/ml ethyl
3-aminobenzoate methanesulfonate (pH 7.4 with NaHCO3) was performed on frogs at the sixth
surgery. All procedures were approved by the University of Sydney and University of
Wollongong Animal Ethics Committees.
Electrophysiological recordings were carried out 2–5 days post cRNA microinjection. Twoelectrode voltage clamp recordings of X. laevis oocytes expressing human nAChRs were
performed at room temperature (21−24°C) using a GeneClamp 500B amplifier and pClamp9
software interface (Molecular Devices, Sunnyvale, CA, USA) at a holding potential ─80 mV.
Voltage-recording and current-injecting electrodes were pulled from GC150T-7.5 borosilicate
glass (Harvard Apparatus, Holliston, MA) and filled with 3 M KCl, giving resistances of 0.3–
1 MΩ. Oocytes were perfused with ND96 solution using a continuous Legato 270 push/pull
syringe pump perfusion system (KD Scientific, Holliston, MA, USA) at a rate of 2 mL/min.
Initially, oocytes were briefly washed with ND96 solution followed by three applications of
half-maximally effective concentration (EC50) of nicotine for hα4β2 nAChRs. Washout with
bath solution for 3 min was carried out between nicotine applications. Oocytes were incubated
with DHβE for 5 min with the perfusion system turned off, followed by co-application of
nicotine and DHβE with flowing bath solution. All solutions were prepared in ND96 + 0.1%
bovine serum albumin.
Data and statistical analysis
Peak current amplitudes before (nicotine alone) and after (nicotine + DHβE) DHβE
incubation were measured using Clampfit version 10.7.0.3 software (Molecular Devices,
Sunnyvale, CA, USA), where the ratio of nicotine + DHβE-evoked current amplitude to
nicotine alone-evoked current amplitude was used to assess the activity of DHβE at hα4β2

nAChRs. (-)-Nicotine hydrogen tartrate salt was from SIGMA (St. Louis, MO, USA) and
DHβE hydrobromide from TOCRIS (Bristol, UK). Fast and slow decay time constants were
obtained from exponential fit function. All electrophysiological data were pooled (n = 5–7) and
represent means ± standard error of the mean (SEM). Data analysis was performed using
GraphPad Prism 5 (GraphPad Prism, RRID:SCR_002798) (GraphPad Software, La Jolla, CA,
USA). The IC50 was determined from concentration-response relationships fitted to a nonlinear regression function and reported with error of the fit. Data sets were compared using
unpaired Student’s t-test. Differences were regarded statistically significant when p < 0.05.
Nomenclature of Targets and Ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in
http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS
Guide to PHARMACOLOGY (Harding et al., 2018), and are permanently archived in the
Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017).

Results
DHβE binding mode and interactions
At the end of the three simulations, the orientation of DHβE molecules in the two binding
sites of α4β2 nAChR was similar to that of the crystal structure of the complex between DHβE
and the Lymnea stagnalis acetylcholine binding protein (AChBP) (Shahsavar et al., 2012)
(Figure 2A,B,C). The MolProbity scores (Williams et al., 2018) of the final frame of each
simulations were between 1.03 and 1.13, corresponding to the 100th percentile, suggesting that
the geometry of the generated models is excellent. During the MD simulations, DHβE was
located approximately at the centre of the orthosteric binding site, which comprises W156,
Y197, and Y204 of the principal subunit and N109 and L121 of the complementary subunit.
The positively charged nitrogen atom of DHβE formed a stable hydrogen bond with the
backbone carbonyl oxygen of W156 and it occupied a position compatible with a cation-π
interaction with the aromatic ring of the same residue (Figure 2D,E). Similar interactions
between DHβE and the receptor were displayed by W143 in the binding site of AChBP
(Shahsavar et al., 2012).
A water molecule entered each binding site during the simulations and created three
hydrogen bonds between the oxygen atom of the DHβE methoxy group and the carboxyl and
nitrogen atoms of N109 and L121, respectively. A similar water molecule is present in the
crystal structure of DHβE in complex with AChBP (Shahsavar et al., 2012). In one binding site

during Simulation 1, the water molecule was exchanged by another that a established similar
hydrogen bond network and remained stable until the end of the simulation (Figure 2E). In
other binding sites and simulations, the bridging water molecule was stable during the entire
simulation (not shown).
Conformation of the C-loop
The opening of the C-loop of the α4 subunit bound with DHβE was ca. 4 Å larger during
the MD simulations than in the crystal structure of α4β2 nAChR bound with nicotine, which is
compatible with an interaction with antagonists (Figure 3A,B and Table S2). The C-loop
opening of ca. 13 Å in our model of the α4β2/DHβE is similar to the binding of antagonists in
crystal structure of AChBP (Figure 3C). In particular, the crystal structure of the complex
between AChBP and DHβE displayed an opening distance of the C-loop similar to our model
of the α4β2 nAChR/ DHβE (Shahsavar et al., 2012).
Relative domain tilting and twisting
Figure 4 shows the evolution of the tilting and twisting angles during the MD simulations
of α4β2 nAChR in complex with DHβE compared to the crystal structure of α4β2
nAChR/nicotine. The average ECD radial tilt angle measured during the MD simulations of
the DHβE-bound α4β2 nAChR was of 4.6 degrees (Figure 4A). By contrast, the nicotine-bound
nAChR crystal structure displayed an ECD radial tilt angle of only 0.4 degrees (Table S4). The
ECD tangential tilt of the DHβE-bound α4β2 nAChR was of 11.1 degrees, which is similar to
the 10.3 degrees measured in the nicotine-bound structure. The relative rotation of the ECD
and of the TMD (ECD-TMD twist angle) initially changed by ~3 degrees compared to the
nicotine-bound structure but became similar over time for Simulations 1 and 3 (Figure 4C). By
contrast, Simulation 2 did not display a “recovery” of the ECD-TMD twist angle until the end
of the simulation. The time traces corresponding to each subunit are not synchronous (Figure
S2), which was observed in earlier molecular simulations of Cys-loop receptors (Calimet et al.,
2013; Liu et al., 2008).
Interface between the ECD and TMD
As illustrated in Figure 5A, the interface between the ECD and TMD comprises a linker
between the ECD β10 strand and the M1 α-helix of the TMD, as well as three loops named β1β2 linker, M2-M3 linker and the Cys-loop. A strong energy coupling was observed between the
central part of the M2-M3 linker and the β1-β2 linker (P271) (Gupta, Chakraborty, Vij, &
Auerbach, 2017), and we used the distance between the central residues of these linkers, which

we call the “activation distance”, to characterise different activation states (Table S2). The
experimental structures of the GlyR, GLIC, and GluCl captured in various activation states
provide evidence that the closed/resting state displays an activation distance that is longer than
that of the open or desensitised states (6–8 Å compared to 4–5 Å). Accordingly, the crystal
structure of α4β2 nAChR in a desensitised state has an ECD-TMD linker distance of 3.7 Å.
The activation distance measured during the MD simulations of the DHβE-bound α4β2 nAChR
was 5.5–6.5 Å, falling in the distance range of resting/closed states (Figure 5B,C).
Tilt of the pore-lining α-helix M2
As shown in Figure 6, the M2 of the DHβE-bound receptor is approximately parallel with
the central axis, with an average radial tilt of only 2.9 degrees, whereas the average radial tilt
angle in the crystal structure of the α4β2 nAChR in a desensitised state is 8.4 degrees. The
average M2 tilt angle of Simulation 3 is 4.3 degrees, which is higher than that of the other two
simulations. This difference originates from a β2 subunit that did not change its tilt orientation
over the course of the simulation (Figure S2). Overall, the ECD of the α4β2 nAChR bound
with DHβE was tilted outward relative to the crystal structure of the α4β2 nAChR in
desensitised state (Morales-Perez et al., 2016) (Figure 4B), and the upper segment of M2 was
measured to have tilted inward compared to the same experimental structure (Figure 6B). An
analysis of most available experimental structures of Cys-loop receptors, shown in Figure 6C,
suggests that this coupled movement of ECD and M2 between the closed/resting and
desensitised states is a general feature of Cys-loop receptors.
Characterisation of the pore in the TMD
As shown in Figure 7A,B, the pore of the channel in the DHβE-bound simulations dried out
between L257 (9’) and L264 (16’) (see Figure S3 for M2 numbering), whereas water molecules
were abundant in this section of the pore at the beginning of the simulation. The upper-region
of the pore, that is surrounding position L264, is more constricted in the DHβE simulations
than in the crystal structure of the desensitised state structure (Morales-Perez et al., 2016)
(Figure 7C,D). The lower-region of the pore displayed a similar trend but to a lesser extent
(Figure 7D), suggesting that the pore transited from a desensitised state to a closed/resting state
by closure of the upper-region of the pore. In addition to a translation toward the centre of the
pore, the M2 helices also rotated along their axis, resulting in a different orientation of the L257
and L264 side chains (Figure 7C). The 9’ position of the TMD was also identified as a gate in
the experimental structures of the GlyR1, GlyR3, GLIC, GluCl, 5-HT3 and ELIC receptors in

the closed/resting state (Table S2). Additionally, the 9’ position is a hydrophobic residue in all
human Cys-loop receptors (Figure S3), suggesting that the gating function of the 9’ position is
conserved across the Cys-loop receptors. Similarly, the 16’ position is also responsible for
gating the TMD in the crystal structures of the bacterial ELIC and GLIC receptors (Table S2,
Figure S4), but it is not a site of constriction for the GlyR1, GlyR3, GluCl and 5-HT3 receptors
(Figure 7D, Table S2), indicating that the function of this position as a gate is not conserved
within the Cys-loop family.
Functional importance of L257 (9’) and L264 (16’)
We experimentally probed the functional importance of α4 L257 (9’) or α4 L264 (16’) by
mutating them individually into Ala and measuring activation and inhibition of the mutated
receptors (Figure 8). The Ala substitutions increased the sensitivity for agonist nicotine by twofold but they had no impact on the inhibition by DHβE (Figure 8A,B). An increased sensitivity
for agonist has been also reported for the α7 L9’V mutation of the homopentameric α7 nAChR
(Revah et al., 1991) but we provide the first identification of nAChR position 16’ influencing
agonist activity. The two mutated positions are distant from the ECD and therefore should not
influence nicotine or the antagonist affinity, as confirmed by the benign substitutions for DHβE
inhibition, but the agonist activity is influenced by the mutations. We propose that the mutations
could destabilise the resting states, facilitating the transition from resting states to open state,
or by stabilizing the open state.
The nicotine (10 μM)-evoked current amplitude was increased more than 20-fold by each
substitution (Figure 8C). A similar increased conductance was reported for 9’ mutants of the
α7 nAChR (Revah et al., 1991); especially the mutation of Leu9’ into Val or small hydrophilic
residues renders permeable one of the fast desensitised states, increasing the number of
conducting states of the channel and therefore conductance (Bertrand et al., 1992; Revah et al.,
1991). Position 9’ is therefore the only hydrophobic gate of at least one of the desensitised
states of the α7 nAChR (Bertrand et al., 1992). For α4β2 nAChR, both the α4[L257A] (L9’A)
and α4[L264A] (L16’A) mutants had increased whole-cell current amplitude, suggesting that
they could be the unique hydrophobic gates of distinct fast-desensitised states. We further
observed that the acetylcholine (ACh) EC50 of the wild-type α4β2 nAChR was 4 μM whereas
the EC50 of L264A mutant was 0.6 μM. A similar increase in the sensitivity of α7 nAChR after
position 9’ mutation was reported and interpreted as stabilisation of a desensitised state by ACh
that is only gated by position 9’ (Revah et al., 1991). The decrease in the ACh EC50 of
α4[L264A]β2 nAChR compared to the wild-type α4β2 therefore suggests the existence of a

desensitised state that is only gated by position 16’. We nevertheless note that the stabilisation
of the open state or an increased single channel conductance are alternative explanations to the
increased current amplitude of the α4[L264A]β2 nAChR mutant.
Consistent with fast desensitised states of the mutated channels becoming leaky, the current
decay time constant of the fast desensitisation component (τf) was prolonged for both
hα4[L257A]β2 and hα4[L264A]β2 compared to the wild-type (Figure 8D). The α4β2 nAChR
appears to behave similarly to the α7 nAChR upon mutation of the 9’ position (Bertrand et al.,
1992; Revah et al., 1991) but the effect of DHβE on these two nAChRs differs. Indeed, DHβE
was shown to activate the [L9’T]α7 nAChR by stabilizing a fast desensitised state that became
permeable with the α7 L9’T mutation (Bertrand et al., 1992). In contrast, we did not observe
the potentiation of the receptor by DHβE for hα4[L257A]β2 and hα4[L264A]β2 (Figure 8B),
indicating that DHβE stabilises a closed state that is not rendered permeable by the α4 L257A
or the α4 L264A mutations, in agreement with our proposed molecular model where both
positions act as gates.
The nicotine-evoked current decay time constant for the slow component (τs) of
hα4[L264A]β2 (L16’A) was comparable to that of the wild-type, whereas that of
hα4[L257A]β2 (L9’A) was significantly prolonged (Figure 8D). We propose two hypotheses
to interpret this result; first is that L257(9’) is important for stabilizing or gating the slow
desensitised state but not L264(16’), and second, the slow desensitised state can only be
reached from fast desensitised states that are destabilised by L257A(9’) substitution (but not
by L264A(16’)). The crystal structure and EM structures of the hα4β2 nAChR have been
proposed to represent a desensitised state, which is probably a slow desensitised state because
the fast desensitised state is short-lived. The pore radius at position 9’ in these structures is
approximately 3.5–4.5 Å (Table S2), which would not prevent conduction, suggesting that
position 9’ is not a gate of the slow desensitised state, potentially invalidating our first
hypothesis. Nevertheless, most experimental structures of eukaryote Cys-loop receptors that
were described as desensitised state display a TMD pore that is more open in the extracellular
side than in the intracellular side (Table S2) (Plested, 2016). Consistent with this model of slow
desensitised state, the L257(9‘) is closer to the intracellular side than L264(16’).

Discussion
We determined the binding mode of the competitive antagonist DHβE at the α4β2 nAChR
using three MD simulations covering a total of 2.6 μs simulation time. The orientation of DHβE

molecules in the two binding sites of α4β2 nAChR was similar to that of the crystal structure
of the complex between DHβE and the Lymnea stagnalis AChBP (Shahsavar et al., 2012).
Invertebrate AChBPs are structural surrogates of the ECD of nAChRs, and have been
extensively used due to their comparatively easier recombinant expression and ability to be
crystallised in complex with various nAChR ligands (Bouzat et al., 2004; Brejc et al., 2001;
Shahsavar, Gajhede, Kastrup, & Balle, 2016). Interestingly, a water molecule entered each
binding site during the simulations and created hydrogen bonds between the DHβE and two
residues from the complementary subunit. Similar water-mediated hydrogen bonds were
observed in the five binding sites of the crystal structure of AChBP bound with DHβE
(Shahsavar et al., 2012). The striking similarity of molecular interactions in the orthosteric
binding sites between DHβE and AChBP or α4β2 nAChR provides strong support to the
practice of using AChBP as a structural surrogate of nAChRs (Shahsavar et al., 2016).
A proposed paradigm of antagonism compared to agonism of nAChRs is that agonists
stabilise the C-loop into a relatively closed conformation whereas antagonist binding results in
a larger opening of the C-loop (Tabassum, Ma, Wu, Jiang, & Yu, 2017). In our simulations, the
C-loop of the α4β2 nAChR/DHβE displayed an open conformation similar to that of the crystal
structure of the complex between AChBP and DHβE (Shahsavar et al., 2012). The C-loop
conformation correlates with the agonist or antagonist activity of the ligand, but the C-loop
itself is not essential for gating as it could be replaced by a poly-glycine linker (Purohit &
Auerbach, 2013).
A comparison of Cys-loop receptor structures reveals that the activation states are
characterised by different relative orientations of domains within each subunit (Nemecz et al.,
2016). These orientations are described in terms of relative tilting (also called “blooming”)
between the ECD and TMD domains of each subunit, and the twisting between the ECD and
the TMD (Cecchini & Changeux, 2015; Gupta et al., 2017; Nemecz et al., 2016). During the
MD simulations of the DHβE-bound α4β2 nAChR from the initial nicotine-bound nAChR
crystal structure, the ECD as a whole experienced a 2.6 degree rotation relatively to the TMD.
Over the course of the MD simulations the structure of the interface between the ECD and
TMD of the α4β2 became similar to that of experimental structures of Cys-loop receptors in a
closed/resting state. The β1-β2 and M2-M3 linkers are crucial for Cys-loop activity (Bouzat,
2012) and undergo conformational changes in different activation states of several Cys-loop
receptors (Nemecz et al., 2016). The activation distance measured during the MD simulations
of the DHβE-bound α4β2 nAChR was 6.0–6.5 Å, suggesting that the receptor adopts a

closed/resting state during the MD simulations. The interaction between the α7 nAChR
embedded in a pure POPC membrane and a large competitive inhibitor peptide, α-conotoxin
ImI, was recently studied using MD simulations (Chiodo, Malliavin, Giuffrida, Maragliano, &
Cottone, 2018). The activation distance of this system was reported to be 12 Å, which is
substantially larger than in our study and compared to other Cys-loop receptor structures.
The coupled movement of ECD and M2 between the closed/resting and desensitised states
is a general feature of Cys-loop receptors. A similar opposite change of direction of ECD and
TMD between the desensitised or open states vs the closed/resting state was also suggested
from MD simulations starting from the crystal structure of GluCl and of the low-resolution EM
structure of the muscle-type nAChR (Calimet et al., 2013; Liu et al., 2008). The closed/resting
states of Cys-loop receptors appear to have, in general, a M2 tilt angle below 5 degrees, whereas
desensitised states have larger values. The pore of the channel in the TMD is lined by the M2
helices, and the change of orientation of these helices consequently impacts the volume of the
pore.
The combination of rotation and translation of the M2 helices contributed to changing the
shape of the pore and the residues responsible for the major constrictions are E247 (-1’), L257
(9’), and L264 (16’). The five E247 residues, one from each subunit, form a ring of negatively
charged residues that selectively filters cations (Bouzat, 2012). We propose that L257 and L264
are the hydrophobic gates responsible for the closing/opening of the channel to the passage of
water and ions. A previous MD study of the low-resolution EM structure of the Torpedo
marmoreta muscle-type nAChR suggested that the hydrophobic gates were at positions 9’ and
13’ (Liu et al., 2008), contrasting with our identification of positions 9’ and 16’. The TMD of
the neuronal and muscle-type nAChRs share a high-sequence identity, and we propose that
either the EM structure used as a starting point of the simulation did not have high enough
resolution or that the computational time used for this simulation was too short to observe a
complete transition to the closed/resting state (30 ns vs 700 ns to 1200 ns in our simulations).
We experimentally probed the functional importance for L257 (9’) and L264 (16’) by
mutating them individually into Ala and measuring activation and inhibition of the mutated
receptors. Overall, the α4 L257A mutation caused a larger current amplitude and prolonged
decay time constant for both the fast and slow components of desensitisation. The L257(9’) is
located in the middle of the TMD and is conserved across Cys-loop receptor families
(Figure S3). The crystal structures of GlyR1, GlyR3, GluCl, GLIC, 5-HT3 and ELIC in
closed/resting state support the hypothesis that the 9’ position forms a hydrophobic gate

(Table S2). The 16’ position is located in the upper segment of the M2, which is less conserved
than L257 (Figure S3). This position is a hydrophobic gate for two bacterial channels, GLIC
and ELIC, in a closed/resting state (Figure S4) but not for the eukaryotic Cys-loop receptors
GlyR1, GlyR3, GluCl, GABAAR and 5-HT3 (Table 2). Our mutagenesis studies suggest
L264(16’) affects the current amplitude (cation influx) and acts as a hydrophobic gate for the
α4β2 nAChR, controlling the transition between the resting, open, and some fast desensitised
states but not to the slow desensitised states.
In summary, MD simulations of α4β2 nAChR bound with DHβE suggested that the receptor
underwent a sequence of structural events resulting in the closure of the ion-pore in the TMD
(Figure 9). Binding of DHβE resulted in a larger opening of the C-loop of the two α4 subunits.
The introduction of DHβE in the binding pocket also resulted in an outward tilting of the ECD
β-sheet core. The outward movement of the ECD was transmitted to the TMD through
communication between the β1-β2 linker and the M2-M3 linker. The β1-β2 linker moved
upward, which resulted in the inward movement of the M2-M3 linker and the upper segment
of the M2 helix. The translation and rotation movements of the M2 helix resulted in
repositioning of the side chains of L257 and L264 in the centre of the pore, causing its closure
(Figure 9). The structure of the antagonist-bound closed/resting state of α4β2 nAChR that we
propose is globally similar to the experimental structures of other Cys-loop receptors in a
closed/resting state, some being bound by antagonist molecules as well. Compared to the
experimental structure of α4β2 nAChR in the desensitised state, the closed/resting state
displays conformational differences in all parts of the receptor. The three simulations that we
carried out led to similar, but not identical, changes of conformations of the receptor, and a
longer simulation time would be required for better convergence, which will hopefully be
possible with increased computational power. In consideration of the limited simulation time,
the final MD relaxed model represents a closed state or a meta-stable conformation leading to
the closed state.
The α4β2 nAChR is the most abundantly expressed subtype in the human brain, and it is
linked to cognition and memory (Grupe, Grunnet, Bastlund, & Jensen, 2015). It is associated
with a range of central nervous system disorders, including depression, attention deficit and
hyperactivity disorders, cognitive impairments and nicotine addiction (Dineley, Pandya, &
Yakel, 2015; Grupe et al., 2015). For example, competitive antagonists targeting the resting
state appear to be important for smoking cessation drugs for attenuating nicotine-induced
reinforcement (Rollema & Hurst, 2018). Competitive nAChR antagonists are also insecticides,

such as triflumezopyrim (DuPont), which is used to control rice grasshoppers (Crossthwaite et
al., 2017). The structure that we propose should therefore be valuable for studying the activity
of therapeutics or insecticidal compounds targeting the closed/resting state of vertebrate and
insect nAChRs.

This Declaration acknowledges that this paper adheres to the principles for transparent
reporting and scientific rigour of preclinical research as stated in the BJP guidelines for Design
& Analysis, and Animal Experimentation, and as recommended by funding agencies,
publishers and other organisations engaged with supporting research.
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Figure 1. Structure of the heteropentameric ligand-gated ion channel α4β2 nAChR. A)
Domain and subunit organisation of the α4β2 nAChR and visualisation of the pore. The α4 and
β2 subunits are colored pink and green, respectively. The α4 and β2 subunits on the front shown
are in cartoon representation and the other three subunits in surface representation. The nAChR
is composed of three domains: an extracellular domain (ECD), a transmembrane domain
(TMD) and an intracellular domain (ICD), the structure of which is unknown and is represented
as fuzzy areas. The crystal structure of the α4β2 nAChR (PDB identifier 5kxi) was used to
draw this figure. A nicotine molecule, colored in orange, is bound in the orthosteric binding
pocket. The pore of the channel is shown in blue, and the approximate location of the membrane
region is shown as a turquoise area. B) Orthosteric binding site occupied by a nicotine
molecule. The A-, B- and C-loops of the α4 subunits are labeled as is the F-loop and several βstrands from the β4 subunit. C) View through the ECD of the central pore from the extracellular
(Ext.) side. D) View through the TMD of the central pore from the intracellular (Int.) side. The
M2 helices of the TMD are lining the pore of the channel.

Figure 2. Binding mode of DHβE in the orthosteric binding site of α4β2 nAChR. A)
Comparison of the binding modes of DHβE at the end of the three simulations and for the two
binding sites of α4β2 nAChR (in total six structures). B) Binding mode of DHβE in the binding
site of AChBP (PDB identifier 4alx). C) Overlay of the binding mode of DHβE in the AChBP
binding site (blue) and in the α4β2 nAChR binding site (pink and green) at the end of
Simulation 1. D) Details molecular interactions of DHβE with the receptor in one of the two
α4(+)β2(-) binding sites in Simulation 1 at 700 ns. E) Evolution of distances between the water
molecules represented in panel A and DHβE as well as between the backbone oxygen of W156
and DHβE during Simulation 1. The gray area represents the distance considered as relevant to
the formation of a hydrogen bond.

Figure 3. Conformation of C-loop of the α4β2 nAChR in complex with DHβE and
comparison with acetylcholine binding proteins (AChBPs) in complex with agonists and
antagonists. A) Superimposition of a molecular model of the complex between α4β2 nAChR
and DHβE (magenta) and of the X-ray crystallographic structure of the human α4β2 nicotinic
receptor interacting with nicotine (blue). The distance used to characterise the C-loop opening
in the α4β2 nAChR was measured between the Cα of Cys199 of the α4 subunit and the Cα of
Ser38 of the β2 subunit. B) Distance characteristic of the C-loop “opening” (averaged between
the two binding sites) during the three MD simulations of α4β2 nAChR/DHβE complex. The
orange dashed line represents the C-loop opening in the nicotine/α4β2 nAChR complex (PDB
identifier 5kxi). C) C-loop opening distance in crystal structures of AChBP in complex with
agonists (green), antagonists (orange) or compounds with dual activity (yellow). The blue zone
represents the approximate boundary between agonists and antagonists. The red dashed line
shows the average C-loop distance measured during the MD simulations of the α4β2
nAChR/DHβE system. The blue dashed lines represent the C-loop opening distance in the
crystal structure of the α4β2 nAChR/nicotine complex. The AChBP structures that were
analyzed in the panel C figure are listed in Table S3. The evolution of the C-loop opening
distance of each binding site for the three simulations is shown in Figure S2.

Figure 4. Domain tilting and twisting during the simulations of α4β2 nAChR bound with
DHβE. A) Radial tilt angle of the ECDs of the α4β2 nAChR in complex with DHβE. B)
Tangential tilt angle of the ECDs of the α4β2 nAChR in complex with DHβE. C) Twist angles
between the ECD and TMD of the α4β2 nAChR bound with DHβE. Data for Simulations 1, 2
and 3 are represented as red, blue and green curves, respectively. The data represented here are
the average of measurements made for the five subunits, and measurements for individual
subunits are shown in Figure S2. The orange dashed line represents the measurement made in
the nicotine/α4β2 nAChR complex (PDB identifier 5kxi).

Figure 5. Interface between the ECD and TMD of the α4β2 nAChR bound with DHβE.
A) Overlay between the final frame of the Simulation 1 (i.e. α4β2 nAChR bound with DHβE)
(magenta) and the crystal structure of the α4β2 nAChR bound with nicotine (cyan). B)
Activation distance measured during the MD simulations of the DHβE/α4β2 nAChR system.
The activation distance was defined in the α4 subunit as the distance between the Cα atoms of
K53 (centre of the β1-β2 linker) and P271 (centre of the M2-M3 linker). In the β2 subunit, the
activation distance is measured between the Cα atoms of R48 (β1-β2 linker) and P263 (M2M3 linker). The orange dashed line indicates the distance in the experimental structure of α4β2
nAChR bound with nicotine (PDB identifier 5kxi). C) Activation distance measured in
experimental structures of several Cys-loop receptors in either open/desensitised or
resting/closed states. The red dashed line represents the average activation distance measured
in the three simulations. Panel B shows the average measurement between the five subunits,
and the measurements made for each subunit are shown in Figure S2.

Figure 6. Comparison of the M2 tilt angle of each subunit of α4β2 nAChR bound with
DHβE and analysis of the tilt angles of Cys-loop receptors. A) Overlay of the M2 α-helix
structures in the last frame (700 ns) of MD Simulation 1 of DHβE (magenta) with the crystal
structure of the α4β2 nAChR in desensitised state (cyan). B) Average M2 tilt angle measured
during α4β2/DHβE MD simulations. The orange dashed line indicates the M2 tilt angle in the
experimental structure of α4β2 nAChR bound with nicotine (PDB identifier 5kxi). The
measurements made for each subunit are in Figure S2. C) Comparison of the ECD radial tilt
and M2 tilt angles for all Cys-loop receptors experimental structure as well as with the last
frame of Simulation 3, which is indicated by a larger black circle labeled with a white C letter.
The activation state of a number of experimental structures has been proposed and labeled with
a letter: C (closed/resting), O (open) or D (desensitised). The unlabeled data points have been
faded for clarity. Arrows have been drawn from the closed/resting conformation to the
desensitised conformation for each Cys-loop receptor. The experimental structures as well as
their corresponding tilt angle values are listed in Table S3.

Figure 7. Pore in the TMD of the α4β2 nAChR when in complex with DHβE. A)
Distribution of water molecules (spheres) in the TMD channel of the α4β2 nAChR bound with
DHβE in the final frame of one of the simulations. B) Number of water molecules passing the
gate L257 over the time of the three simulations. Simulations 1, 2 and 3 are in red, blue, and
green, respectively. C) Overlay of the structures of the M2 helices forming the pore in the TMD
in the final frame of Simulation 1 of the α4β2/DHβE complex (magenta) and of the crystal
structure of the desensitised state (PDB identifier 5kxi, cyan) as viewed from the extracellular
side of the membrane. D) Comparison of the TMD channel radius profiles of the α4β2 nAChR
and GlyR3 in closed/resting and desensitised states. The radius profiles were computed using
Hole. Residues L257 (9’) and L264 (16’) create the main constrictions in the pore radius
profiles and these gate residues are shown in stick representation in Panels A and C.

Figure 8. Electrophysiological characterisation of α4β2 nAChR mutated at positions α4
L257 or α4 L264. A) Concentration-response relationship of relative nicotine-evoked current
amplitude mediated by human α4β2 (hα4β2), hα4[L257A]β2 and hα4[L264A]β2 nAChRs. The
EC50 values of hα4β2, hα4[L257A]β2 and hα4[L264A]β2 nAChRs were of 276.7 ± 14.2 nM,
117.2 ± 4.7 nM and 109.9 ± 3.2 nM (mean ± SEM, n = 5), respectively. B) Concentrationresponse relationship of relative nicotine-evoked current amplitude mediated by hα4β2,
hα4[L257A]β2 and hα4[L264A]β2 nAChRs in the presence of 10 pM-1 μM dihydro-βerythroidine (DHβE). The IC50 values (mean ± error of the fit) of DHβE at hα4β2,
hα4[L257A]β2 and hα4[L264A]β2 nAChRs were of 10.1 ± 0.6 nM, 9.7 ± 0.6 nM and
12.6 ± 0.9 nM (n = 5-7 oocytes for each concentration), respectively. The variation in n was
due to the viability of oocytes during experiments. C) Nicotine (10 μM)-evoked current
amplitude of hα4β2, hα4[L257A]β2 and hα4[L264A]β2 nAChRs (mean ± SEM, n = 5, *
p < 0.05 unpaired Student’s t-test compared to hα4β2). D) hα4β2, hα4[L257A]β2 and
hα4[L264A]β2 nACh-mediated current decay time constant of the fast (τf) and slow (τs)
components evoked by 10 μM nicotine (mean ± SEM, n = 5, * p < 0.05 unpaired Student’s ttest compared to hα4β2). E) Mechanistic model of hα4β2 nAChR activation states. The
positions 9’ and 16’ in the TMD are represented as gates that could block the channel in two
independent fast desensitised states.

Figure 9. Schematic representation of the conformation changes occurring during the
transition from a desensitised state to a closed/resting state for the α4β2 nAChR. Arrows
indicate the motion of the ECD, M2, loops (C-loop, β1-β2 linker and M2-M3 linker) and of the
side chains of the L264 and L257 residues. Constriction points in the channel are represented
by black crosses. The parts of the channel available to cations are illustrated by blue dots.

